138 related articles for article (PubMed ID: 37515961)
1. A erythrocyte-platelet hybrid membrane coated biomimetic nanosystem based on ginsenosides and PFH combined with ultrasound for targeted delivery in thrombus therapy.
Yang MY; Tu YF; Feng KK; Yin MD; Fang YF; Le JQ; Luo BY; Tan XR; Shao JW
Colloids Surf B Biointerfaces; 2023 Sep; 229():113468. PubMed ID: 37515961
[TBL] [Abstract][Full Text] [Related]
2. A Synergistic and Efficient Thrombolytic Nanoplatform: A Mechanical Method of Blasting Combined with Thrombolytic Drugs.
Hu L; Xu J; Zhang W; Wang J; Fang N; Luo Y; Xu L; Liu J; Zhang Y; Ran H; Guo D; Zhou J
Int J Nanomedicine; 2022; 17():5229-5246. PubMed ID: 36388875
[TBL] [Abstract][Full Text] [Related]
3. Folate-modified erythrocyte membrane nanoparticles loaded with Fe
Wang X; Li P; Jing X; Zhou Y; Shao Y; Zheng M; Wang J; Ran H; Tang H
Front Oncol; 2022; 12():864444. PubMed ID: 36033521
[TBL] [Abstract][Full Text] [Related]
4. Platelet membrane-cloaked selenium/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy.
Yin M; Lin J; Yang M; Li C; Wu P; Zou J; Jiang Y; Shao J
Colloids Surf B Biointerfaces; 2022 Jun; 214():112464. PubMed ID: 35334311
[TBL] [Abstract][Full Text] [Related]
5. Low-Intensity Focused Ultrasound-Responsive Phase-Transitional Nanoparticles for Thrombolysis without Vascular Damage: A Synergistic Nonpharmaceutical Strategy.
Zhong Y; Zhang Y; Xu J; Zhou J; Liu J; Ye M; Zhang L; Qiao B; Wang ZG; Ran HT; Guo D
ACS Nano; 2019 Mar; 13(3):3387-3403. PubMed ID: 30855938
[TBL] [Abstract][Full Text] [Related]
6. Drug Release from Gelsolin-Targeted Phase-Transition Nanoparticles Triggered by Low-Intensity Focused Ultrasound.
Qin H; Teng R; Liu Y; Li J; Yu M
Int J Nanomedicine; 2022; 17():61-71. PubMed ID: 35023919
[TBL] [Abstract][Full Text] [Related]
7. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy.
Xu Z; Huang J; Zhang T; Xu W; Liao X; Wang Y; Wang G
J Mater Sci Mater Med; 2023 Apr; 34(4):18. PubMed ID: 37043085
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic nanoparticles: U937 cell membranes based core-shell nanosystems for targeted atherosclerosis therapy.
Shen JW; Li C; Yang MY; Lin JF; Yin MD; Zou JJ; Wu PY; Chen L; Song LX; Shao JW
Int J Pharm; 2022 Jan; 611():121297. PubMed ID: 34822966
[TBL] [Abstract][Full Text] [Related]
9. Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi.
Bai S; Liao J; Zhang B; Zhao M; You B; Li P; Ran H; Wang Z; Shi R; Zhang G
Biomater Sci; 2020 Sep; 8(18):5047-5060. PubMed ID: 32830839
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy.
Zhao Z; Li X; Wang Y; Liu C; Ling G; Zhang P
J Nanobiotechnology; 2023 Nov; 21(1):439. PubMed ID: 37990207
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
12. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
13. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
[TBL] [Abstract][Full Text] [Related]
14. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
15. A nanosystem loaded with perfluorohexane and rose bengal coupled upconversion nanoparticles for multimodal imaging and synergetic chemo-photodynamic therapy of cancer.
Wang HY; Hou L; Li HL; Wang X; Cao Y; Zhang BY; Wang JT; Wei SJ; Dang HW; Ran HT
Biomater Sci; 2020 May; 8(9):2488-2506. PubMed ID: 32211626
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell membrane coated PLGA nanoparticles as biomimetic drug delivery system for improved cancer therapy.
Li Y; Ke J; Jia H; Ren J; Wang L; Zhang Z; Wang C
Colloids Surf B Biointerfaces; 2023 Feb; 222():113131. PubMed ID: 36646005
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte Membrane-Coated Invisible Acoustic-Sensitive Nanoparticle for Inducing Tumor Thrombotic Infarction by Precisely Damaging Tumor Vascular Endothelium.
Xie H; Li W; Liu H; Chen Y; Ma M; Wang Y; Luo Y; Song D; Hou Q; Lu W; Bai Y; Li B; Ma J; Huang C; Yang T; Liu Z; Zhao X; Ding P
Small; 2022 Jul; 18(30):e2201933. PubMed ID: 35789094
[TBL] [Abstract][Full Text] [Related]
18. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus.
Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C
ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407
[TBL] [Abstract][Full Text] [Related]
19. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
20. An erythrocyte membrane-modified biomimetic synergistic nanosystem for cancer anti-vascular therapy and initial efficacy monitoring.
Zhang J; Li F; Su L; Hu Q; Li J; Zhu X
J Mater Chem B; 2023 Aug; 11(30):7160-7168. PubMed ID: 37403599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
